Hereditary Disease Screening Kits

Molecular diagnostic kits for genetic testing applications across hereditary conditions and disease susceptibility screening. Supports preventive medicine and personalized health assessment protocols.

Genetic testing assays for hereditary disease screening and molecular diagnostics.

Diagnostic kits for identifying genetic predispositions and rare genetic disorders without requiring DNA extraction. Supports rapid and personalized diagnostic assessment for optimal care management.

Diagnostic kits for early detection and screening of major chronic diseases. Encompasses multiple disease categories with focus on populations at high risk for cardiovascular, metabolic, and degenerative conditions.

Kits for detection and analysis of genetic markers relevant to disease diagnosis and patient stratification. Enables molecular characterization of genetic variations in patient samples. Applied in clinical genetics and molecular pathology settings.

PCR-based kits designed to detect specific gene mutations and polymorphisms associated with malignancy. These products enable targeted molecular analysis for precision tumor diagnosis.

Genetic polymorphism detection kits for identifying genetic variations associated with drug metabolism, disease susceptibility, and therapeutic response. These in vitro diagnostic kits enable clinicians to personalize treatment decisions based on individual genetic profiles, supporting pharmacogenomics and precision medicine applications in clinical laboratories.

Specialized diagnostic kits for early cancer screening and detection. Targets major cancer types affecting Asian and Chinese populations with focus on preventive medicine applications.

PCR-based systems for genetic mutation and polymorphism detection. Supports pharmacogenomics and inherited disease diagnosis.

Comprehensive screening kits for detection of common infectious diseases including viral and bacterial pathogens. Widely used in clinical laboratories and epidemic monitoring programs.

Laboratory test kits for metabolic disorder and genetic condition identification in clinical settings.

Cancer screening kits utilizing microfluidic chip, fluorescent qPCR, and isothermal amplification technologies for precision detection of tumor markers and genetic variants. Designed for early cancer diagnosis, treatment selection, and recurrence monitoring across multiple cancer types. Enables rapid, accurate results for clinical screening and personalized oncology applications.